NuMe Among Firms With Gut Feeling About Burgeoning Prebiotics Space
This article was originally published in The Tan Sheet
Executive Summary
Prebiotics could grow from a currently “nonexistent” market to surpass the flourishing probiotics category in both revenues and supporting science, the chief executive of a prebiotics developer says.
You may also be interested in...
OTC Probiotics Face Challenging Regulatory Framework
The development of OTC drugs based on probiotics requires a regulatory system more receptive to research on the microorganisms' use as therapeutic ingredients, according to microbiologist Gary Huffnagle.
New Products In Brief
Arbonne launches diversified supplements
Probiotic Firms Must Overcome Barriers To Cash In On High Growth
U.S. consumer spending on probiotics is poised to grow 8.8% in five years, but ingredient firms breaking into the category must compete against entrenched market leaders, a senior industry analyst with Frost & Sullivan says.